Amwell Announces Results for Third Quarter 2024
Amwell (NYSE: AMWL), a leading provider of healthcare software as a service, reported its third quarter 2024 financial results for the period ending Sept. 30, 2024. The company will host a conference call today at 5 p.m. ET to discuss these results. The call can be accessed via a live audio webcast on Amwell's investor relations website or by dialing 1-888-510-2008 for U.S. participants and 1-646-960-0306 for international participants, using conference ID number 7830032. A replay will be available shortly afterward on the same website.
Amwell (NYSE: AMWL), un fornitore leader di software per la salute come servizio, ha riportato i suoi risultati finanziari del terzo trimestre 2024 per il periodo che si è concluso il 30 settembre 2024. L'azienda ospiterà una conference call oggi alle 17:00 ET per discutere di questi risultati. La chiamata sarà accessibile tramite una diretta audio sul sito web delle relazioni con gli investitori di Amwell o componendo il numero 1-888-510-2008 per i partecipanti degli Stati Uniti e 1-646-960-0306 per i partecipanti internazionali, utilizzando il numero di identificazione della conferenza 7830032. Una registrazione sarà disponibile poco dopo sullo stesso sito web.
Amwell (NYSE: AMWL), un proveedor líder de software de atención médica como servicio, reportó sus resultados financieros del tercer trimestre de 2024 para el período que finalizó el 30 de septiembre de 2024. La compañía ofrecerá una conferencia telefónica hoy a las 5 p.m. ET para discutir estos resultados. La llamada se podrá acceder a través de una transmisión de audio en vivo en el sitio web de relaciones con inversores de Amwell o llamando al 1-888-510-2008 para los participantes de EE. UU. y 1-646-960-0306 para los participantes internacionales, usando el número de identificación de la conferencia 7830032. Una reproducción estará disponible poco después en el mismo sitio web.
Amwell (NYSE: AMWL)은 의료 소프트웨어를 서비스로 제공하는 선도적인 기업으로, 2024년 9월 30일에 종료된 기간 동안의 2024년 3분기 재무 결과를 보고했습니다. 회사는 오늘 오후 5시(동부표준시)에 이 결과를 논의하기 위한 전화 회의를 개최할 예정입니다. 이 회의는 Amwell의 투자자 관계 웹사이트에서 실시간 오디오 웹캐스트를 통해 접근 가능하며, 미국 참가자는 1-888-510-2008, 국제 참가자는 1-646-960-0306으로 전화를 걸어 회의 ID 번호 7830032를 사용하여 참여할 수 있습니다. 회의 후, 같은 웹사이트에서 녹음된 내용을 곧바로 이용할 수 있습니다.
Amwell (NYSE: AMWL), un fournisseur leader de logiciels de santé en tant que service, a annoncé ses résultats financiers du troisième trimestre 2024 pour la période se terminant le 30 septembre 2024. L'entreprise tiendra une conférence téléphonique aujourd'hui à 17 h, heure de l'Est, pour discuter de ces résultats. L'appel peut être accédé via un webinaire audio en direct sur le site web des relations investisseurs d'Amwell ou en composant le 1-888-510-2008 pour les participants aux États-Unis et le 1-646-960-0306 pour les participants internationaux, en utilisant le numéro d'identification de la conférence 7830032. Un enregistrement sera disponible peu après sur le même site web.
Amwell (NYSE: AMWL), ein führender Anbieter von Software-as-a-Service im Gesundheitswesen, hat seine Finanzergebnisse für das dritte Quartal 2024 für den Zeitraum, der am 30. September 2024 endet, veröffentlicht. Das Unternehmen wird heute um 17:00 Uhr ET eine Telefonkonferenz abhalten, um diese Ergebnisse zu besprechen. Die Konferenz kann über ein Live-Audio-Streaming auf der Investor-Relations-Website von Amwell oder durch Wählen der Nummer 1-888-510-2008 für Teilnehmer aus den USA und 1-646-960-0306 für internationale Teilnehmer unter Verwendung der Konferenz-ID-Nummer 7830032 erreicht werden. Eine Wiederholung wird kurz danach auf derselben Website verfügbar sein.
- None.
- None.
BOSTON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the third quarter ended Sept. 30, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the third quarter 2024 earnings report.
The company will host a conference call to discuss its financial results today at 5 p.m. ET, Oct. 30. The call can be accessed via a live audio webcast at investors.amwell.com or by dialing 1-888-510-2008 for U.S. participants or 1-646-960-0306 for international participants, referencing conference ID number 7830032. A replay of the call will be available via webcast shortly after the completion of the call, at the same web link.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
FAQ
What were Amwell's financial results for the third quarter of 2024?
When will Amwell discuss its third quarter 2024 financial results?
How can I access Amwell's third quarter 2024 earnings call?
Where can I find the replay of Amwell's third quarter 2024 earnings call?
